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This newsletter was jointly developed and 
subject to editorial review by Jefferson 
School of Population Health and Lilly 
USA, LLC, and is supported through 
funding by Lilly USA, LLC. The content 
and viewpoints expressed are those of the 
individual authors, and are not necessarily 
those of Lilly USA, LLC or the Jefferson 
School of Population Health.
As dean of one of the nation’s leading 
schools of population health, I would be 
remiss if I didn’t devote special attention to 
this critically important concept. 
With 45% of us suffering from at least 
1 chronic condition1 and more than 49 
million of us lacking health insurance,2 
the need for a population health approach 
in the United States has never been more 
urgent. Without exaggeration, the scope 
of today’s population health challenge 
is unprecedented, particularly when it 
is coupled with the unrelenting upward 
spiral of health care costs and the declining 
health status of the general population (as 
compared with previous generations). 
Whatever shape it may take eventually, 
population health will be essential to 
the success of health care reform. Why? 
Because it takes aim at the some of the 
very basic shortcomings in our traditional 
health care delivery system: namely, 
enhancing health and wellness through 
prevention and lifestyle changes, reducing 
or eliminating waste and error, eradicating 
disparities, improving transparency 
and accountability, and improving care 
coordination – a goal shared with health 
care reform. 
Population health looks beyond public 
health at “the distribution of health 
outcomes within a population, the health 
determinants that influence distribution, 
and the policies and interventions that 
impact those determinants.”3,4 It spans 
wellness and health promotion, chronic 
disease management, care of the frail 
and elderly, and palliative and end-of-life 
care. In essence, broad population health 
approaches are designed to preserve 
wellness and minimize the physical and 
financial impact of illness. 
How does the Patient Protection and 
Affordable Care Act (ACA) incorporate 
the principles of population health? First 
and foremost, it creates a new framework 
for health care delivery in the United 
States by adopting a comprehensive 
national strategy for quality improvement, 
the focus of which is clinically integrated 
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systems-based practice. This should 
result in care that is coordinated across 
all diseases, providers, and care settings 
over time. Importantly, hospitals and 
health systems will be required to extend 
their quality oversight processes as they 
pursue collaborative relationships with 
physicians and other entities.
The Accountable Care Organization 
(ACO) program, a prominent feature 
of the ACA, will have a major influence 
on extending quality oversight processes 
to outpatient settings,5 which is where 
Americans receive the overwhelming 
majority of their health care services. 
A shared savings model, the ACO will 
require participating providers to use the 
tools of population-based care to achieve 
the cost savings necessary for success. 
The patient-centered medical home and 
ACO models that feature prominently 
in health reform contain aspects of care 
delivery that fall under the umbrella 
of population health. These efforts 
and related new payment models are 
an attempt to identify and eliminate 
waste and inefficiencies in the system. 
Today, much of the emphasis of health 
reform is on these new payment models 
that seek to improve quality and cost-
effectiveness in the system. However, for 
true success in this environment, explicit 
new methods for delivering care must 
be part of the overall plan. Rather than 
simply following the rules of reform, 
health care leaders must fully understand 
and follow the intricately related tenets 
of population-based care as these will 
have a major influence. 
At this point, I’ll segue to a brief 
overview of the articles featured in 
this issue of our series on how various 
provisions of the ACA have begun to 
affect health care quality and population 
health. This issue delves into 3 
important areas: 
“Accountable Care: Will it Transform 
Health Care Delivery?” takes us through 
the concepts, competencies, regulatory 
constraints, and challenges associated 
with the deployment of ACOs. The 
author observes that it won’t be a 
cakewalk, but there are opportunities 
for success. 
“Health Care Payment Reform: A Look 
Ahead” takes a hard look at the issues 
related to, and the likely impact of, new 
payment models for health care delivery. 
The final article, “Rethinking Health 
Information Technology on the Journey 
to Personalized Medicine,” reflects 
on how secondary use of existing 
health information can hasten the 
development of more individualized 
care - an exciting prospect! 
I hope that this issue will serve to 
enlighten and provoke discussion 
around the linked concepts of health 
reform and population health. As 
always, I welcome questions and 
comments from our readers. I can be 
reached at: david.nash@jefferson.edu.
David B. Nash, MD, MBA, is the Dean 
and the Dr. Raymond C. and Doris N. 
Grandon Professor of Health Policy at 
the Jefferson School of Population Health 
(JSPH) of Thomas Jefferson University 
in Philadelphia, PA. 
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By now the public may know the 
Supreme Court ruling on key aspects 
of the ACA: the individual mandate, 
severability of the mandate from 
some or the entire 2700-page law, 
and Medicaid expansion.  
The individual mandate requires 
that all citizens (not currently 
enrolled in a public health program) 
purchase health insurance. Various 
models have been created to forecast 
the impact of a court decision 
invalidating the individual mandate 
while maintaining the other 
components of the ACA. These 
forecasts range from an exponential 
increase to a significant reduction in 
persons seeking insurance. 
A Message from Lilly
The Opportunity to Create Policy Insights via the Implementation of the Patient 
Protection and Affordable Care Act (ACA)
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 If the entire law is struck down, 
Congress may act quickly to 
reinstate some of the provisions that 
generate revenue or are valued by 
the public, or gridlock may continue. 
This debate will play out alongside 
presidential and congressional 
elections in November. Everything 
could look completely different 
politically in 2013. 
So, although the future of health 
care for the current uninsured is 
uncertain, it is a fact that ACA 
implementation is under way. This is 
evident on many levels:
•  Over 2.5 million young adults 
have enrolled in their parents’ 
insurance plans.
•  129 million Americans have 
gained coverage as a result of 
the elimination of preexisting 
condition restrictions.
•  Demonstration projects have 
been initiated to improve care 
and reduce costs in Medicare 
and Medicaid.
•  The federal government has 
received revenue from the private 
sector in various ways. 
Significantly, many states have 
already begun to evaluate and 
prepare to implement state-based 
insurance exchanges – a more 
organized and competitive market 
for buying health insurance. As 
of March 2012, thirteen states 
plus the District of Columbia had 
legislatively established state-based 
exchanges while 3 more states have 
announced their intent to create 
these entities.1 For those states 
that move forward with exchange 
implementation (regardless of the 
Supreme Court decision), the health 
policy field will benefit from very 
public case studies. 
The exchanges will be organized at 
the state level while incorporating a 
federally defined basic level of care 
(the Essential Health Benefits). Per 
the ACA, the state exchanges must 
address 10 service categories2 but their 
average standard of care is driven 
by local standards (based on small 
and large employer plans, Medicaid 
plans, and the federal employee health 
benefits program). And, the insurance 
providers in each state will have to 
propose plans that relate actuarially 
to that average standard of care. 
More information is available online 
at: http://cciio.cms.gov/resources/
regulations/index.html#hie.
Watching these state implementations 
raises interesting policy questions 
that today’s scholars might want to 
consider. Here are a few and I suspect 
you can think of more:
•  Can the states tailor care standards 
to their specific populations and 
achieve better outcomes because 
of variability between state plans?
•  What state model of basic services 
provides the best outcomes for 
the overall population as well as 
specific patient populations?
•  Do exchanges work without 
federal subsidies (if the Court 
strikes down the ACA) or 
can state-level oversight drive 
improvements in quality and 
reductions in cost more rapidly 
and effectively than the federal 
government (if the Court 
upholds the ACA)? 
Karen L. Friss, BS, MBA is Senior 
Director, Global Public Policy at Eli 
Lilly and Company.
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What is an Accountable Care Organization? 
The Patient Protection and Affordable 
Care Act describes an Accountable 
Care Organization (ACO) as a group 
of providers of services and suppliers 
“willing to become accountable for the 
quality, cost, and overall care of the 
Medicare beneficiaries assigned to it.” 
Additional characteristics of the ACO 
include a formal legal structure with 
shared governance; appropriate 
Accountable Care: Will it Transform Health Care Delivery?
By Allan B. Goldstein, MD, MPH 
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leadership and management structure; 
processes to promote evidence-based 
medicine, patient engagement, and 
care coordination; mechanisms to 
report on quality, patient experience, 
and cost measures; and creation of an 
environment of patient-centeredness.1
Although other ACO definitions and 
descriptions have been formulated, 
the common denominator is that 
provider groups working together will 
be accountable for a defined population 
and employ measurable outcomes as 
criteria.2 The accountable care model 
takes many of the disparate threads of 
health care reform and weaves them 
into an integrated fabric. From another 
perspective, accountable care may be 
viewed as a health care delivery model 
that optimally employs standardized 
processes and tools, measurement, and 
information-driven improvement to 
achieve its goals. Because a broad range of 
delivery systems meet these requirements, 
the ACO structure allows for both 
flexibility and diversity in delivery system 
design as we learn more about this model 
and refine it based on experience.
Key Organizational Competencies 
Organizations may need a tool to 
help them understand what it means 
to be an ACO, as well as to evaluate 
the status of their current operational 
capabilities and to identify the gaps they 
must fill to qualify as an ACO. One 
such benchmarking tool, developed 
by Premier Inc., has established 6 
key organizational competencies 
required to perform the functions of 
an ACO (Premier Accountable Care 
Organization Capabilities Framework 
Assessment Tool, unpublished data, 
2011). These core competencies are 
shown in Figure 1.
Each component is divided into 
Capabilities and subdivided into 
Operating Activities, each of which 
constitutes a discrete core competency 
the organization must develop to 
become an ACO. With more than 
150 operating activities (Premier 
Accountable Care Organization 
Capabilities Framework Assessment 
Tool, unpublished data, 2011), the task 
of organizational transformation to an 
ACO will be a prodigious undertaking. 
Figure 1 provides a visual 
representation of the relationships 
among these key components as 
interpreted by Premier’s Accountable 
Care Collaborative.
Regulatory Constraints 
On March 31, 2011, the Centers 
for Medicare and Medicaid Services 
(CMS) published proposed rules for 
Medicare contracting with ACOs.3 
Following receipt of extensive feedback 
from a broad range of stakeholders 
regarding the regulatory constraints 
imposed by the proposed rules, CMS 
published final rules governing the 
implementation of the Medicare 
Shared Savings Program (MSSP) on 
November 2, 2011.4 Four requirements 
in the final rules represent significant 
obstacles to provider entities that are 
considering creating ACOs to serve 
the Medicare population. 
First, CMS acknowledged that 
provisions of the Physician 
Self-Referral Law, the Federal 
antikickback statute, and the civil 
monetary penalties law “may impede 
development of some of the innovative 
integrated-care models envisioned 
by the” MSSP.5 In conjunction with 
the Office of the Inspector General, 
CMS established 5 unique waiver 
requirements covering a variety of 
arrangements that ACOs might need 
to undertake in order to be successful 
at carrying out the MSSP.6 
The Internal Revenue Service has 
provided guidance for 501(c)(3) not- 
for-profit corporations that participate 
in the MSSP through an ACO, 
enumerating those circumstances 
under which the not-for-profit entity 
could avoid impermissible inurement 
or private benefit that would adversely 
impact its status.7 Organizations 
forming ACOs also must satisfy 
state anticompetitive rules. Creating 
a legal and governance structure 
that conforms to all the regulatory 
requirements will be a challenging 
early step for prospective ACOs.
Second, beneficiary assignment for 
the MSSP will be retrospective based 
on the “plurality of their primary care 
services during the performance year.”8 
CMS acknowledges the challenges 
this creates for the prospective ACO 
that must develop and implement a 
Figure 1.  The Accountable Care Organization:  
Conceptual Architecture
Core Components:
• People-Centered Foundation 
• Health Home 
• High-Value Network 
• Population Health Data Management 
• ACO Leadership 
• Payor Partnerships
© 2010 Premier, Inc. Used With Permission.
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population management strategy for a 
population that is defined after the fact. 
Third, in response to extensive 
comments and criticism of the proposed 
quality reporting requirements, the 
final rule requires ACOs to report on 
33 quality measures (instead of 65) 
spanning 4 quality domains (patient/
caregiver experience of care, care 
coordination/patient safety, preventive 
health, and at-risk populations).8 
Although this reduction in the number 
of reportable quality measures (and 
employment of nationally endorsed 
measures already in use) mitigates 
the magnitude of the data collection 
and reporting requirement for ACOs, 
33 measures represent a significant 
administrative burden for most 
organizations. In addition, there is 
concern that ACOs will manage to the 
metrics rather than focusing on other 
meaningful process improvements that 
may not impact the metrics. 
Fourth, ACO receipt of shared 
savings is subject to meeting quality 
performance targets and exceeding a 
minimum savings rate of 2.0%-3.9% 
below the applicable benchmark. The 
ACO will be eligible for a maximum 
shared savings rate of 50% (1-sided 
model) or 60% (2-sided model). 
Calculation of benchmarks and actual 
payments from CMS will be subject to 
a variety of adjustments that may make 
cash flow projections difficult.9 
Organizations will be required to make 
substantial up-front investments to 
create the requisite ACO infrastructure. 
However, it may be several years before 
the ACO generates savings and it remains 
unclear if the savings realized will be 
adequate to repay the initial investment, 
motivate behavior change by providers, or 
create a sustainable business model.
Critical Challenges to Accountable Care 
Deployment  
In many localities, the hospital is the 
only care delivery entity with the 
organizational and financial resources 
to develop an ACO. Hospitals have 
been acquiring primary care and select 
specialty practices at an accelerated rate 
over the last several years. Collaborations 
between hospitals and physicians have 
a troubled history marked by mistrust 
and competition for lucrative services.10 
Converting physicians to hospital/health 
system employees does not obviate the 
need to align physicians’ goals with those 
of their new employers and to make 
necessary attitudinal and behavioral 
changes. Many physicians may fear their 
loss of autonomy, and resist efforts to 
standardize care delivery processes and 
measure performance against objective 
metrics. Overcoming such resistance will 
be essential to ACO success.
Establishing the infrastructure necessary 
to support an accountable care delivery 
system will require considerable capital 
investment. CMS has estimated the 
initial ACO development investment at 
$1.8 million, but the American Hospital 
Association estimates that $5.3 to $12.0 
million will be needed, depending on 
system size and complexity.11 These 
figures do not include the ongoing cost 
of ACO operations, which is estimated 
at $6.3 to $14.1 million annually. These 
costs will be incurred regardless of the 
ACO’s success or its ability to earn 
shared savings. Despite such substantial 
investment, organizations have no 
guarantee that there will be a return 
on investment or that accountable care 
represents a sustainable, long-term 
business model.
Accountable care will challenge the basic 
tenets of today’s health care system. 
Although providers are currently paid 
on a piecework basis, they can expect 
numerous efforts to foster alternative 
payment mechanisms. Long viewed as a 
major revenue generator for the delivery 
system, the hospital will become a cost 
center, as will all other care delivery 
settings. Hospitals will become the focus 
of intense efforts to eliminate waste and 
duplication with the goal of maximizing 
system efficiency and value. 
Transforming to an accountable delivery 
system will not occur at a fixed point 
in time. Rather, it will occur over an as 
yet undetermined span of time. During 
this transition phase, providers will be 
operating in a care delivery environment 
with a split personality. Managing 
through that transition will be one of the 
most difficult challenges for future ACOs.
Opportunities for Early Success 
The Health Home represents a major 
innovative advance in primary care and is 
a foundational prerequisite for a successful 
ACO. Despite significant energy and 
resources currently dedicated to Health 
Home deployment, these transformed 
practices still represent a small fraction of 
the primary care delivery system. ACO 
deployment can facilitate and support the 
rapid expansion and adoption of Health 
Homes, resulting in higher quality, 
patient-centered care. Embedding case 
management services within the Health 
Home and concentrating efforts on the 
sickest patients will improve coordination 
of patient services and reduce costs.12 In 
addition, coordinating care transitions can 
dramatically reduce hospital readmissions.
A corollary to ACO implementation is 
the commitment to make clinical quality 
improvement part of the organization’s 
core business strategy. Reduction of 
unwanted variation in physicians’ practices 
is an excellent place to begin these efforts. 
By selecting high-volume, high-cost 
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treatments and focusing on care delivery 
processes, the organization can embed 
evidence-based clinical practice guidelines 
into the flow of clinical activities. With 
20 years of experience using this model, 
Intermountain Healthcare estimates that 
it can reduce clinical costs by 6%-10% 
while improving clinical outcomes.13 Once 
physicians are provided with relevant, 
actionable information and see the impact 
of process improvement activities, they 
will drive most of the changes themselves. 
Process improvement has been shown to 
reduce the frequency of adverse events 
and avoidable deaths in the hospital.14
Potential Downstream Consequences of 
Adopting Accountable Care 
Many changes will occur in the health 
care landscape over the next 10 years. 
The adoption of ACOs is expected 
to accelerate the pace at which these 
changes take place.
In the future, US health care will be 
dominated by competing, vertically 
integrated delivery systems comprising 
a diverse group of provider stakeholders 
and, potentially, insurers. The integrated 
delivery system will be a risk-taking 
entity accountable for a defined 
population of patients. Customer service 
will be a foundational element of the 
delivery system and critical to its success. 
System performance will be measured 
using broadly accepted cost, quality, and 
patient experience metrics. 
The Health Home will be the system 
point of entry and the center for care 
delivery and coordination. Disease and 
case management services will emanate 
from the Health Home. Primary care 
practices will be larger and linked into 
self-managing networks. Non-affiliated 
solo and small group practices will not 
be financially viable business options. 
An increasing percentage of patient 
encounters will be provided by e-visits, 
group visits, and in the home setting.
Reimbursement systems that align 
incentives and reward performance 
will predominate. Fee-for-service 
reimbursement will be the exception 
rather than the norm.
Medical schools and hospitals will 
recalibrate projected manpower 
needs (both the number and type of 
practitioners), training, and deployment. 
Inpatient facilities will have fewer beds, a 
higher proportion of which will provide 
intensive care.
Those insurance companies that have not 
partnered or merged with an integrated 
delivery system will focus on core 
competencies of marketing and claims 
processing. Some will become vendors 
for other services such as disease and case 
management or actuarial services.
Currently, accountable care is the 
vehicle driving these changes. However, 
if ACOs fail to meet the challenge, 
other economic, demographic, and 
governmental forces will step in. In any 
event, transformation of the American 
health care delivery system is inevitable.
Allan B. Goldstein, MD, MPH, is the 
Founder and Principal, Goldstein Health 
Care Consulting, LLC. He can be reached 
at: allanbg626@gmail.com.
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The public debate about raising the 
federal debt limit—and Standard and 
Poor’s downgrading the rating of federal 
bonds—have contributed to a growing 
consensus that controlling federal 
spending should be an urgent national 
priority. Controlling federal spending on 
health care must be a central part of that.
Figure 1 lays out the issue visually: the 
Congressional Budget Office projections 
for federal spending (as a percentage of 
gross domestic product) show inexorable 
growth to levels that are clearly 
unacceptable. But, when the spending 
is broken down into its components, 
we see that the projected growth is 
driven entirely by outlays for health 
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care; specifically Medicare, Medicaid, 
the state Children’s Health Insurance 
Program, and projected subsidies for the 
Health Insurance Exchanges created by 
the Affordable Care Act (ACA). The 
problem of rising health care costs is not 
merely a threat to health care; it is a very 
real threat to the sustainability of the 
American economy.
Long-term control of health care 
costs—or, more desirably, long-term 
improvements in the value of health 
care—will require fundamental reform of 
our health care system and, in particular, 
fundamental change in the organization 
and operation of health care delivery 
systems across the country. Given the 
indispensable role of physicians in 
delivering health care and shaping the 
processes through which it is delivered, 
it is inconceivable that necessary changes 
can take place without the active and 
willing participation of those who 
practice medicine. And therein lies the 
concern; many physicians are neither 
active nor willing partners in effecting the 
process changes that must accompany 
health care reform. 
Health care reform is seen by some as a 
threat to physician income. The new law 
is, after all, the Patient Protection and 
Affordable Care Act, and affordability can 
translate into pressure on the incomes 
of all health care providers. More often 
though, health care reform is equated with 
accountability; indeed, many people think 
that “ACA” stands for the Accountable 
Care Act. For physicians, accountability 
has come to mean public reporting, 
compliance, and the considerable costs 
associated with them. It should come as 
no surprise that, as they are understood by 
physicians, affordability and accountability 
offer little to make health care reform an 
appealing and attractive proposition.
Solving the Problem: The Central Role of 
Payment Reform 
Although improving the value of health 
care will require movement on several 
fronts, new ways of paying for care are 
likely to be central to efforts. Clearly, 
delivery system reconfiguration is the 
“end game” but, as Donald M. Berwick, 
MD put it, “Every system is perfectly 
designed to achieve exactly the results it 
gets.”1 Fee-for-service (FFS) payment for 
health care services drives service volume 
and intensity. If we want a delivery system 
that drives value, we must change the way 
we pay for health care. 
If there is any good news, it is that 
the political will to take on the issue 
of payment reform appears to have 
reached a tipping point. On one hand, 
the budgetary issues that have driven 
federal debt have intensified pressure to 
act. On the other hand, there is growing 
acceptance of the premise that the current 
formula for Medicare adjustments to 
physician payments—the “Sustainable 
Growth Rate”—is not “fixable” and 
that some other methodology must 
replace it. In fact, the Medicare Payment 
Advisory Commission has issued 
recommendations to move away “from 
the Sustainable Growth Rate System,”  
to “shift Medicare payment policies  
away from FFS,” and to “make FFS  
less attractive.”2
There are several alternatives that 
could “shift Medicare payment policies 
away from FFS”—alternatives that 
vary substantially with respect to the 
performance risk they create for providers. 
At one end of the risk spectrum is 
“salary.” Salaried physicians have income 
predictability, but very little upside (and 
virtually no downside) risk to that income. 
At the other end of the spectrum are 
“bundled” or “episode-based” payments, 
and global or “population-based” 
payments. Under these systems, physician 
income may have considerable upside 
potential but there often is considerable 
downside risk. Figure 2 is a brief, high-
level summary of alternative payment 
strategies plotted along a risk continuum. 
Of course, variation is possible in each of 
these payment themes and the strategies 
for combining them.
Which strategy/strategies are “best” 
for achieving the optimal results? The Source: CBO’s 2011 Long-Term Budget Outlook. Washington, DC: Congressional Budget Office; June 22, 2011. 
CBO=Congressional Budget Office, CHIP=Children’s Health Insurance Program
Figure 1.   Actual and projected federal outlays as a percentage of Gross Domestic 
Product (GDP).
(continued on page 8)
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evidence is still accumulating. It seems 
likely, though, that almost any strategy 
can work in some settings—and that 
almost none can work in all settings. So, 
the challenge will be to understand what 
type of payment model works best in a 
particular context or setting.
Physicians and Financial Risk 
Given the importance of risk as a 
motivator of change—and the variation 
in risk implicit in different payment 
models—it is necessary to consider how 
physicians respond to risk. Historically, 
physicians have not managed risk well, 
and many have been inclined to avoid 
it to the extent possible. At the limit, 
avoiding risk is best achieved through 
salaried employment, and we have seen 
more and more physicians embracing that 
model. But there are strategies to mitigate 
risk as opposed to avoiding it completely.
One such strategy is affiliating with an 
entity that is better prepared to accept 
and to manage risk. Physicians and 
medical groups are motivated to affiliate 
with larger, better capitalized (hence 
more risk-tolerant) organizations such as 
integrated delivery systems, physician-
hospital organizations, and larger 
medical groups or Independent Practice 
Associations, which function as large, 
virtual medical groups. As part of these 
larger entities, physicians are insulated 
from some of the risk that attends more 
advanced payment models.
At the other end of the spectrum, some 
physicians and medical groups have 
prepared (or are preparing) themselves 
to understand and accept financial risk, 
and are seeking to be paid in ways that 
offer significant upside opportunity. To 
manage risk, these groups had to acquire 
new actuarial and care management 
skills and invest in the information, 
knowledge, and care management 
infrastructure required to understand 
and respond to clinical risk. These 
investments require size and scale as well 
as considerable capital. 
Where Are We Headed? 
We are in the early stages of a period of 
rapid change. The specific shape of that 
change is difficult to predict and, almost 
certainly, the course will be one marked 
by frequent correction. That said, I 
believe that there are certain givens or, at 
the very least, likely outcomes: 
-  There will be progressive expansion of 
the number and intensity of risk-based 
payment options
We are already seeing some 
experimentation, and I expect that 
promising models for replacing FFS 
will be scaled rapidly. Much of the 
experimentation is occurring in the 
private sector where pressure for change 
is intense, but regulatory constraints 
on innovation may be less binding. 
It is very important to note that the 
Center for Medicare and Medicaid 
Innovation (“the Innovation Center” 
at the Centers for Medicare and 
Medicaid Services [CMS]) has recently 
announced a Bundled Payment for 
Care Improvement initiative,3 which 
complements CMS’s Acute Care 
Episode demonstration.4 Together, and 
with the construction of a Medicare-
specific Episode Grouper (Section 3003 
of the ACA requires that the Secretary 
develop a Medicare-specific episode 
grouper by January 1, 2012),5 these 
strategies suggest that Medicare may 
be able – and inclined - to introduce 
bundled payments into the mainstream 
of Medicare in the foreseeable future.
-  Vertical integration in health care will 
continue…
Although the response to the Medicare 
Shared Savings Program (MSSP) 
may be limited, the marketplace 
clearly understands the inevitability of 
“accountable care,” and is responding 
in a variety of ways to create entities 
that are better able to coordinate care 
and manage risk. Although these 
responses are quite pleomorphic, many 
appear to be steps on a path toward 
structural integration: in particular, 
“clinical integration” achieved through 
the acquisition of physician practices 
by hospitals. 
… but there will be more and more  
virtual integration
Structural integration is a vehicle to 
accomplish the coordination of care 
necessary to achieve better clinical and 
financial outcomes; however, it is only one 
way in which hospitals, physicians, and 
other providers can achieve those ends. 
Although they offer certain advantages, 
it is important to note that truly 
integrated systems (eg, Geisinger) are not 
built quickly and more nimble, virtual 
structures are likely to continue to emerge. 
Some of the models being developed in 
Figure 2. Payment Strategies as a function of Provider Risk  
FFS=fee for service, PCMH=patient-centered medical home
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the private sector6 may be in response to 
the MSSP, and to the Innovation Center’s 
Bundled Payment Initiative.
-  There will be many bumps in the road
Although there is a path forward, 
the direction is clearer than the 
topography. At a time when there  
is intense pressure to respond, there 
will be some missteps. “Nimbleness” 
will be a critical success factor.  
 
One of the central challenges that 
will need to be addressed—and one 
that can be anticipated and managed 
affirmatively—is potential resistance 
among practicing physicians. Physician 
resistance to change in payment and 
delivery system organization will, at a 
minimum, create inertia and friction.  
At the limit, they could cause gridlock.  
 
Physician resistance is not inevitable 
but, for the reasons outlined earlier, is 
probable. In general, health care reform 
represents a threat to physicians who may 
perceive the cornerstones of reform—
“affordability” and “accountability”—as 
forces that exert pressure on their 
income and autonomy. A recent survey 
by the Massachusetts Medical Society 
suggests that the majority of physicians, 
for example, would not participate in a 
voluntary bundled payment program, 
and only about half would participate 
in a voluntary Accountable Care 
Organization.7 At the same time, many 
physicians are dissatisfied with the 
current health care system, and many 
would welcome change if that change 
would allow them to practice medicine as 
the professionals they are. 
So, among the critical requirements for 
making the necessary changes in the 
payment and delivery systems are:
1.  An understanding of what 
physicians perceive as a better way 
to deliver care, and 
2.  Recognition that the tools and 
additional supports needed by 
physicians to reconfigure their 
practices must be made available in 
parallel with – or in advance of -  
the policy changes that will force 
the reconfiguration. 
Transforming health care means 
changing the way physicians practice. 
For success under the new set of rules 
that will guide the transformation, we 
must ensure that physicians are equipped 
with the knowledge and tools they need.
Cary Sennett, MD, PhD is the President of 
IMPAQ International. He can be reached 
at: [csennett@impaqint.com].
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Rethinking Health Information Technology on the Journey to Personalized Medicine 
By Brett J. Davis
Health care and life sciences 
organizations have long recognized  
the potential for a convergence of 
their 2 disciplines, envisioning a 
bidirectional information pipeline 
between bench and bedside that 
would facilitate the development 
of more personalized and effective 
treatments. For several years, the 
health care community has struggled 
to make progress on this front in 
the face of multiple challenges that 
range from institutional objections to 
change, to security/privacy concerns, 
to inadequate funding, to technology 
limitations. 
With global health systems under 
unprecedented strain, the realization of 
personalized medicine has never been 
more imperative – and, in the wake of 
breakthroughs in our understanding 
of biology at the molecular level, it has 
never been more possible. 
Although the health care industry is 
poised for progress, a significant hurdle 
remains: Building the right information 
technology (IT) infrastructure to support 
the new data management challenges of 
this paradigm. Many IT systems being 
adopted across research and care domains 
today were not designed to permit the 
secondary data uses that are necessary for 
research and personalized care. To a great 
extent, these existing transactional systems 
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support individual silos across the health 
science ecosystem that impede - and in 
many cases prevent - the integrated view 
of data that is essential for collaborative 
research activities including management 
of genotypic and phenotypic data, 
analytical secondary uses of health 
data, and the ultimate realization of 
personalized medicine.
To move forward, health sciences 
organizations must take a different 
approach to their health care IT 
infrastructures – an approach that 
enables large-scale reuse of the vast 
volume of health care information that 
is locked in today’s transactional systems. 
New platforms will be required to enable 
health care information exchange among 
organizations. New analytic solutions will 
be necessary to answer the most difficult 
questions in health care: What works, for 
whom, why, in what context, and at what 
cost? The next generation of health care 
IT systems has the potential to be truly 
transformational and usher in a new era 
of health care delivery but a critical first 
step is recognizing that today’s systems 
were not designed to get us there. 
Industry at a Crossroad 
Over the past 25 years, the world has 
seen an unprecedented expansion of 
scientific knowledge as a result of 
breakthroughs in imaging, genomics, 
proteomics, diagnostics, and other 
disciplines. These breakthroughs promise 
to deliver precision medicine for some 
of the most complex and debilitating 
diseases (eg, cancer, Alzheimer’s disease, 
Parkinson’s disease) as well as prevalent 
chronic conditions such as diabetes.
At the same time, global health systems 
are nearing their breaking points. Like 
other developed nations, the United 
States is struggling with skyrocketing 
costs associated with aging populations 
and the management of increasingly 
expensive chronic conditions. The 
United States also must address the 
serious issues of inconsistent quality and 
outcomes that are not commensurate 
with the dollars expended. 
Even after accounting for variations in 
wealth, the Organization for Economic 
Cooperation and Development estimates 
that approximately 31% of total US 
health care expenditures are “excess” in 
comparison with other member nations.1 
In the United States alone, estimates of 
the tab for unwarranted care range from 
$250 billion to $325 billion annually.2 
Another example of “wasted” care is that 
many major classes of drugs do not work 
for a large percent of the population who 
take them each year. For example, 38% of 
patients with depression, 50% of patients 
with arthritis, 40% of patients with 
asthma, and 43% of patients with diabetes 
will not respond to initial treatment.3  
Personalized medicine represents a 
potential way forward. It can help 
address cost and quality challenges 
by promoting targeted therapies and 
interventions for the patient populations 
most likely to benefit from them. If built 
using a data driven approach, it can 
sustain and accelerate new discoveries 
and innovations that advance prevention 
or improve outcomes. 
A Perfect Climate for Change
At a time when it is most needed, the 
health care industry is experiencing a 
convergence of developments that present 
an opportunity to achieve substantial 
progress on the path to personalized 
medicine. Each of these developments 
requires new information management 
platforms beyond today’s clinical systems.
First, scientific advances in the last 
decade are providing valuable insight 
into the reasons why some patients 
may be more susceptible to particular 
conditions and/or respond differently to 
specific treatments. With the completion 
of the Human Genome Project, we 
have entered an exciting new era that 
is yielding a broader understanding of 
health and disease at a molecular level. 
We are realizing important benefits, 
such as the ability to assess genetic risk 
for certain types of cancer or to predict 
which individuals may react positively 
or negatively to a particular treatment. 
Most experts expect the rapid pace of 
advancement in scientific understanding 
to continue for many years to come.
The second important trend is a 
fundamental shift in the approach to 
health care reimbursement. For example, 
the United States has begun a transition 
from its traditional fee-for-service model 
to a pay-for-value approach that rewards 
outcomes. The Patient Protection and 
Affordable Care Act of 2010 (ACA) 
will expand a number of programs that 
were piloted by the Centers for Medicare 
and Medicaid Services in the last 
decade. Specifically, Medicare’s launch 
of the Hospital Value-based Purchasing 
Program in October 2012 will mark the 
beginning of a fundamental shift in how 
Medicare pays health care providers and 
facilities. Under the new program, US 
hospitals will be paid for inpatient acute 
care services based on care quality - not 
just the quantity of the services they 
provide. Many private insurers are also 
experimenting with new reimbursement 
strategies that reward value and outcomes.
Finally, comparative effectiveness 
research (CER) initiatives also factor 
into the mix of activities that are likely 
to reshape how health care organizations 
treat patients. The ACA authorizes 
the creation of a nonprofit corporation 
known as the Patient-Centered 
Outcomes Research Institute, the 
purpose of which is to assist patients, 
clinicians, purchasers, and policy makers 
to make informed health decisions 
through CER. The Institute supplants 
the Federal Coordinating Council for 
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Comparative Effectiveness Research, 
established under the American 
Recovery and Reinvestment Act of 2009, 
which allocated $1.1 billion for CER.
A Fractured Frame 
With the necessary scientific and 
policy components in place to advance 
personalized medicine, the industry 
now must address the technological 
barriers. To be effective, health care 
organizations must reconfigure their 
information infrastructures to enable 
large-scale secondary use of the health 
care data that is locked in their existing 
transactional systems (Figure 1). 
Secondary use of data captured in 
transactional systems across the 
health care ecosystem (eg, electronic 
health records, claims/billing systems, 
clinical trial management systems, 
research databases, clinical and 
laboratory systems) is essential to 
enable and accelerate the new paradigm 
of personalized health care. The 
information-based transformation of 
health care to a more personalized 
health care paradigm is conceptualized 
in the “learning health care framework” 
first introduced in a 2007 Institute of 
Medicine Study. 
A majority of today’s health care IT 
systems were created to automate specific 
workflows (eg, research, back office, 
direct care); hence, they are fragmented 
from a data perspective. The secondary 
use of data captured in core transactional 
systems is required for analysis that 
affords insight. In order to support a 
rapid-learning, value-based, personalized 
health care paradigm, data from these 
source systems must be “freed” and 
aggregated for secondary data usage. 
For example, there are many financial, 
supply chain, claims, and billing systems 
that can determine costs within a health 
care organization; however, these systems 
cannot correlate these data with the actual 
cost of treating a patient for a specific 
condition or calculate the outcome of that 
treatment. The initial goal of capturing 
the data was to track a set of procedures 
in order to bill a payer and/or patient for 
the services rendered. In a value-based 
reimbursement system, organizations 
must be able to access, aggregate, and 
analyze these data to correlate costs and 
outcomes across patient populations.
The IT implications for this new 
paradigm are significant, particularly 
with respect to the need for secure 
exchange of data between systems and 
the analytics necessary to glean insights 
from the secondary use of the data in 
these systems. 
Recognizing this need, the industry has 
begun to make the investments necessary 
to create interoperability between 
transactional systems and analytics 
platforms for the analysis of that data. 
As stated previously, most transactional 
IT systems adopted across the research 
and care domains today were purpose 
built (ie, not designed, developed, or 
implemented with the requirements 
of value-based personalized medicine 
in mind). These systems fall short 
on multiple fronts; most importantly, 
their failure to collect the necessary 
information in the right context and 
their inability to provide the necessary 
linkage between financial, operational, 
research, and clinical data and processes. 
Building a New Foundation 
Value-based personalized medicine 
requires the ability to manage, integrate, 
analyze, and leverage clinical, financial, 
claims, and other biomedical information 
from across the health care enterprise 
and from external sources.
Two fundamental technologies will 
drive the transformation. The first is 
an interoperable health information 
exchange that will aggregate and 
normalize data from core transactional 
systems and enable health care providers 
and researchers to act on it. In today’s 
multi-vendor environments, integration 
standards and repeatable processes 
are critical to providing adequate data 
management capabilities. Building the 
right infrastructure to support data 
collection, integration, and transformation 
is essential to enabling new insights. 
The second essential IT component, 
enterprise analytics, will drive more 
productive use of secondary health 
data on a wide scale. In the business 
bestseller, Competing on Analytics, 
authors Tom Davenport and Jeanne 
Harris make important distinctions 
between capabilities that enable access 
and reporting and those that provide 
true analytical insights. Much of the 
business intelligence industry has focused 
on capabilities that enable reporting, 
structured or ad hoc queries, and 
(continued on page 12)
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Figure 1. Multiple Applications of 
Secondary Use of Health Care Data
Health Care Providers
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decision support
Academic Medical Centers
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Adapted from Transforming Healthcare Through Secondary  
Use of Health Data. PricewaterhouseCoopers (PCW); 2009.
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alerts that make delivery of surfacing 
information to decision makers more 
efficient. Davenport and Harris 
point out that the next level of value 
will be through more predictive and 
optimization-oriented solutions and 
practices.4 Their careful analysis of 
high-performing companies across 
multiple industries found a substantial 
correlation between the extensive use 
of analytics among high performers 
versus low performers.4 
The same approach applies to the 
business and delivery of health care as 
well. Health care organizations require 
retrospective and predictive analytics 
that span enterprise data. Only then will 
they acquire the necessary insight to 
predict the likely outcome of a specific 
course of treatment for a specific patient 
in real time. With these tools, providers 
also may be able to gain a better 
understanding of the true cost of care 
and more accurately predict important 
outcomes such as the likelihood for 
readmission, the precise treatment for 
an individual’s genotype and phenotype, 
or the risk of adverse events.
In the short term, the industry is 
deploying various stopgap measures. 
End users’ need to glean some insights 
from existing transactional systems 
is driving investment in expensive, 
limited, one-off data marts and 
analytics environments. This, in turn, is 
generating more silos and complexity 
in health systems’ IT environments. 
Without exaggeration, this is a very 
complex and thus expensive way to 
approach analytics.
As health care organizations come 
to realize the importance of analytics 
systems, they are beginning to invest 
in enterprise-class, interoperable 
analytics platforms. This is true 
for biopharmaceutical companies, 
payers, and providers as well as 
academic medical centers. Health 
care organizations should think about 
these investments in the context of 
their trading partners. By investing in 
more robust information management 
architecture, organizations extend their 
ability to share data with other partners. 
In addition to leading to greater 
innovation, such investments can create 
new opportunities for collaboration.
A Platform Approach Accelerates Change 
Historically, the process of creating 
and implementing a data model, 
building an enterprise data warehouse, 
and creating customized analytical 
applications has been a very expensive 
and lengthy undertaking - one that 
is beyond the resources of all but the 
largest of health care organizations. In 
essence, this approach requires health 
care organizations to be software 
development shops. An alternative 
to this expensive, complex approach 
is a platform-based approached to 
analytics solutions. The move toward 
a “productized” platform enables 
enterprise analytical applications and 
reduces costs and implementation 
timelines, thereby making the 
technology more accessible for health 
sciences organizations of all sizes. 
Conclusion 
Secondary use of electronic health care 
data can answer the hard questions in 
health care: What works for whom, 
why, in what context, and at what cost? 
To enable secondary use of health 
data and drive the advancement of 
personalized medicine, health sciences 
organizations require an integrated 
view across disparate transactional 
systems. This calls for a robust 
enterprise model that is optimized for 
analytics versus transactions. Once 
such a model is in place, the use of 
well-defined and well-integrated 
analytics throughout the health care 
value chain can be transformative. 
Given the immense size of the 
data challenge, the distinctness and 
geographic spread of many health 
care-related activities, and the fact 
that so many health care activities are 
conducted by different companies and 
organizations that must interact with 
each other, there is really no other way 
to provide the tools necessary to enable 
and deliver personalized medicine and 
to control spiraling costs.
Brett Davis is Senior Director, Strategy 
and Business Development, at Oracle 
Health Sciences. He can be reached at: 
brett.davis@oracle.com
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